Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health

Zulueta J, Wisnivesky J, Henschke C, Yip R, Farooqi A, McCauley D . Emphysema scores predict death from COPD and lung cancer. Chest. 2011; 141(5):1216-1223. PMC: 3415146. DOI: 10.1378/chest.11-0101. View

Kraus W, Powell K, Haskell W, Janz K, Campbell W, Jakicic J . Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. Med Sci Sports Exerc. 2019; 51(6):1270-1281. PMC: 6527136. DOI: 10.1249/MSS.0000000000001939. View

Drummond M, Buist A, Crapo J, Wise R, Rennard S . Chronic obstructive pulmonary disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014; 11 Suppl 3:S154-60. PMC: 5473655. DOI: 10.1513/AnnalsATS.201312-432LD. View

Gonzalez G, Ash S, Vegas-Sanchez-Ferrero G, Onieva J, Rahaghi F, Ross J . Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography. Am J Respir Crit Care Med. 2017; 197(2):193-203. PMC: 5768902. DOI: 10.1164/rccm.201705-0860OC. View

Yang X, Wisselink H, Vliegenthart R, Heuvelmans M, Groen H, Vonder M . Association between Chest CT-defined Emphysema and Lung Cancer: A Systematic Review and Meta-Analysis. Radiology. 2022; 304(2):322-330. DOI: 10.1148/radiol.212904. View

Ito Fukunaga M, Wiener R, Slatore C . The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same…. JAMA Oncol. 2021; 7(5):684-686. PMC: 8743068. DOI: 10.1001/jamaoncol.2020.8376. View

Mets O, Smit E, Mohamed Hoesein F, Gietema H, Bokkers R, Attrach M . Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One. 2012; 7(7):e42227. PMC: 3407100. DOI: 10.1371/journal.pone.0042227. View

Xia C, Rook M, Jan Pelgrim G, Sidorenkov G, Wisselink H, van Bolhuis J . Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study. Eur J Epidemiol. 2019; 35(1):75-86. PMC: 7058676. DOI: 10.1007/s10654-019-00519-0. View

Bhatt S, OConnor G . Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities. JAMA. 2022; 327(18):1768-1770. DOI: 10.1001/jama.2022.3823. View

10.

Steiger D, Siddiqi M, Yip R, Yankelevitz D, Henschke C . The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD. Clin Imaging. 2021; 78:136-141. DOI: 10.1016/j.clinimag.2021.03.012. View

11.

Gazourian L, Thedinger W, Regis S, Pagura E, Price L, Gawlik M . Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study. Respir Med. 2020; 176:106245. PMC: 7890561. DOI: 10.1016/j.rmed.2020.106245. View

12.

El Kaddouri B, Strand M, Baraghoshi D, Humphries S, Charbonnier J, van Rikxoort E . Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. Radiology. 2020; 298(2):441-449. PMC: 8824777. DOI: 10.1148/radiol.2020200563. View

13.

Divo M, Cote C, de Torres J, Casanova C, Marin J, Pinto-Plata V . Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(2):155-61. DOI: 10.1164/rccm.201201-0034OC. View

14.

Yip R, Jirapatnakul A, Hu M, Chen X, Han D, Ma T . Added benefits of early detection of other diseases on low-dose CT screening. Transl Lung Cancer Res. 2021; 10(2):1141-1153. PMC: 7947380. DOI: 10.21037/tlcr-20-746. View

15.

Lynch D, Moore C, Wilson C, Nevrekar D, Jennermann T, Humphries S . CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study. Radiology. 2018; 288(3):859-866. PMC: 6122195. DOI: 10.1148/radiol.2018172294. View

16.

Martinez F, Han M, Allinson J, Barr R, Boucher R, Calverley P . At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018; 197(12):1540-1551. PMC: 6006401. DOI: 10.1164/rccm.201710-2028PP. View

17.

Heiden B, Engelhardt K, Cao C, Meyers B, Puri V, Cao Y . Association between lung cancer screening and smoking cessation. Cancer Epidemiol. 2022; 79:102194. DOI: 10.1016/j.canep.2022.102194. View

18.

Smith M, Wrobel J . Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014; 9:871-88. PMC: 4154888. DOI: 10.2147/COPD.S49621. View

19.

Mangione C, Barry M, Nicholson W, Cabana M, Caughey A, Chelmow D . Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2022; 327(18):1806-1811. DOI: 10.1001/jama.2022.5692. View

20.

Coxson H, Dirksen A, Edwards L, Yates J, Agusti A, Bakke P . The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med. 2014; 1(2):129-36. DOI: 10.1016/S2213-2600(13)70006-7. View